Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2.7M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Mar 5 | TEVA | Teva Pharmaceutical… | SSELL◷ | 7,924 | $31.67 | $250.9K | -8.5% | Open the original filing on SEC.gov |
| Mar 5 | TEVA | Teva Pharmaceutical… | MEXER◷ | 17,819 | — | — | +23.8% | Open the original filing on SEC.gov |
| Mar 4 | TEVA | Teva Pharmaceutical… | AGRANT◷◆ | 50,643 | — | — | — | Open the original filing on SEC.gov |
| Mar 4 | TEVA | Teva Pharmaceutical… | MEXER◷◆ | 20,461 | — | — | — | Open the original filing on SEC.gov |
| Mar 4 | TEVA | Teva Pharmaceutical… | SSELL◷ | 9,098 | $32.46 | $295.4K | -10.8% | Open the original filing on SEC.gov |
| Mar 4 | TEVA | Teva Pharmaceutical… | MEXER◷ | 20,461 | — | — | +32.1% | Open the original filing on SEC.gov |
| Nov 20, 2025 | TEVA | Teva Pharmaceutical… | MEXER◷◆ | 63,492 | — | — | — | Open the original filing on SEC.gov |
| Nov 20, 2025 | TEVA | Teva Pharmaceutical… | SSELL◷ | 28,229 | $24.78 | $699.5K | -30.7% | Open the original filing on SEC.gov |
| Nov 20, 2025 | TEVA | Teva Pharmaceutical… | MEXER◷ | 63,492 | — | — | +223.7% | Open the original filing on SEC.gov |
| Nov 14, 2025 | TEVA | Teva Pharmaceutical… | SSELL | 30,000 | $25.11 | $753.3K | -51.4% | Open the original filing on SEC.gov |